ADVANTAGES OF VAC POSTOPERATIVE ABDOMINAL WALL WOUND COMPLICATIONS TREATMENT IN CANCER PATIENTS

Summary. Introduction. Postoperative abdominal wall wound infevtions became significant problem om modern surgery impacting approximatly 110,800 patients in 2015. Aim of study. Comparison of postoperative abdominal wall wound complications treatment methods in cancer patients. Materials and method. 24 cases of patients with purulent-septic complications of postoperative wounds were analised. 10 (41,6 %) — men and 14 (58,4 %) — women. The average age of patients was 63,8±17,1 years. Patients were divided into two groups: a comparative group — 12 patients (routine treatment), and an experimental group — 12 patients, which was treated using the VAC system. Both groups received infusion and antibacterial therapy. Research results. In cultures of wound contents, the following were found: (1) Staphylococcus aureus — 38,9 %, (2) Staphylococcus epidermidis — 19,5 %, (3) Enterococcus faecalis — 19,1 %, (4) Escherichia coli — 15,4 %, (5) Pseudomonas aeruginosa — 5,8 %, (6) Proteus vulgaris — 0,9 %, as well as (7) gram-positive aerobic and facultatively anaerobic pathogens — 0,4 %. According to the results of bacteriological examination of the wound contents in the patients of the experimental group, the microbial count decreased statistically significantly (to 105-106, p>0,05) starting from the third day of treatment. In the comparative group — all indicators remained at the previous levels (108-109). Conclusions. VAC-therapy appeared superior in postoperative abdominal wall wound complications treatment in cancer patients. VAC significantly reduces both duration of hospital stay and mortality.